Patents by Inventor Mark Forrest GORDON

Mark Forrest GORDON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR THE TREATMENT OF DYSKINESIA IN CEREBRAL PALSY
    Publication number: 20240082225
    Abstract: The disclosure is directed to methods of treating dyskinesia in cerebral palsy in human patients using deutetrabenazine and its active metabolites.
    Type: Application
    Filed: June 28, 2023
    Publication date: March 14, 2024
    Inventors: Juha-Matti Savola, Mark Forrest Gordon, Frank Schneider
  • USE OF PRIDOPIDINE FOR TREATING DYSTONIAS
    Publication number: 20240075021
    Abstract: The invention provides a method of treating a subject afflicted with a dystonia, comprising periodically administering to the subject a pharmaceutical composition comprising an amount of pridopidine effective to treat the subject.
    Type: Application
    Filed: October 19, 2023
    Publication date: March 7, 2024
    Applicant: Prilenia Neurotherapeutics Ltd.
    Inventors: Michael HAYDEN, Spyridon PAPAPETROPOULOS, Juha-Matti SAVOLA, Eli EYAL, Beth BOROWSKY, Igor D. GRACHEV, Mark Forrest GORDON
  • Use of pridopidine for treating dystonias
    Patent number: 11826361
    Abstract: The invention provides a method of treating a subject afflicted with a dystonia, comprising periodically administering to the subject a pharmaceutical composition comprising an amount of pridopidine effective to treat the subject.
    Type: Grant
    Filed: February 24, 2019
    Date of Patent: November 28, 2023
    Assignee: PRILENIA NEUROTHERAPEUTICS LTD
    Inventors: Michael Hayden, Spyridon Papapetropoulos, Juha-Matti Savola, Eli Eyal, Beth Borowsky, Igor D. Grachev, Mark Forrest Gordon
  • METHODS FOR THE TREATMENT OF DYSKINESIA IN CEREBRAL PALSY
    Publication number: 20220409597
    Abstract: The disclosure is directed to methods of treating dyskinesia in cerebral palsy in human patients using deutetrabenazine and its active metabolites.
    Type: Application
    Filed: April 12, 2022
    Publication date: December 29, 2022
    Inventors: Juha-Matti Savola, Mark Forrest Gordon, Frank Schneider
  • Methods for the treatment of dyskinesia in cerebral palsy
    Patent number: 11324732
    Abstract: The disclosure is directed to methods of treating dyskinesia in cerebral palsy in human patients using deutetrabenazine and its active metabolites.
    Type: Grant
    Filed: December 13, 2019
    Date of Patent: May 10, 2022
    Assignee: Auspex Pharmaceuticals, Inc.
    Inventors: Juha-Matti Savola, Mark Forrest Gordon, Frank Schneider
  • METHODS FOR THE TREATMENT OF DYSKINESIA IN CEREBRAL PALSY
    Publication number: 20200188371
    Abstract: The disclosure is directed to methods of treating dyskinesia in cerebral palsy in human patients using deutetrabenazine and its active metabolites.
    Type: Application
    Filed: December 13, 2019
    Publication date: June 18, 2020
    Inventors: Juha-Matti Savola, Mark Forrest Gordon, Frank Schneider
  • USE OF PRIDOPIDINE FOR TREATING DYSTONIAS
    Publication number: 20190192496
    Abstract: The invention provides a method of treating a subject afflicted with a dystonia, comprising periodically administering to the subject a pharmaceutical composition comprising an amount of pridopidine effective to treat the subject.
    Type: Application
    Filed: February 24, 2019
    Publication date: June 27, 2019
    Applicant: PRILENIA THERAPEUTICS DEVELOPMENT LTD.
    Inventors: Michael HAYDEN, Spyridon PAPAPETROPOULOS, Juha-Matti SAVOLA, Eli EYAL, Beth BOROWSKY, Igor D. GRACHEV, Mark Forrest GORDON